Labcorp Holdings Inc. (LH) Earnings Call Analysis
NYSE · Healthcare · Diagnostics & Research
Earnings Reports
-
LabCorp (LH) Q2 2026: Central Lab Drives 10% Growth, Margin Expansion Outpaces Diagnostics
July 30, 2026
-
LabCorp (LH) Q1 2026: Central Lab Revenue Jumps 11% as Specialty and AI Initiatives Drive Margin Expansion
April 30, 2026
-
LabCorp (LH) Q4 2025: Esoteric Testing Mix Rises to 41.5%, Fueling Margin Expansion and Specialty Growth
February 24, 2026
-
LabCorp (LH) Q3 2025: Diagnostics Margin Expands 110 bps as Specialty Testing and M&A Drive Mix Shift
October 28, 2025
-
LabCorp (LH) Q2 2025: Specialty Volumes Drive 9% Diagnostics Growth, Bolstering Guidance and Margins
July 24, 2025
-
Labcorp (LH) Q1 2025: Diagnostics Margin Expands 50bps Ex-Weather, Invitae Integration Accelerates
July 07, 2025